TY - JOUR
T1 - Irritable Bowel Syndrome
T2 - What Treatments Really Work
AU - Alammar, Nuha
AU - Stein, Ellen
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2019/1
Y1 - 2019/1
N2 - Irritable bowel syndrome (IBS) is present in patients with symptoms of chronic abdominal pain and altered bowel habits but no identifiable organic etiology. Rome IV classification groups patients based on predominant stool pattern. Low-FODMAP diets have been helpful in providing symptom relief, as have cognitive behavioral and mind-body techniques that help patients manage symptoms. Targeted symptomatic relief for the patient's predominant symptoms provides relief in addition to effective older medications that are inexpensive and reliable. Newer treatments for IBS-D, such as eluxadoline, and IBS-C, with linaclotide, lubiprostone, plecanatide, also can provide durable relief.
AB - Irritable bowel syndrome (IBS) is present in patients with symptoms of chronic abdominal pain and altered bowel habits but no identifiable organic etiology. Rome IV classification groups patients based on predominant stool pattern. Low-FODMAP diets have been helpful in providing symptom relief, as have cognitive behavioral and mind-body techniques that help patients manage symptoms. Targeted symptomatic relief for the patient's predominant symptoms provides relief in addition to effective older medications that are inexpensive and reliable. Newer treatments for IBS-D, such as eluxadoline, and IBS-C, with linaclotide, lubiprostone, plecanatide, also can provide durable relief.
KW - Constipation
KW - Diarrhea
KW - Irritable bowel syndrome (IBS)
KW - Rome criteria
UR - http://www.scopus.com/inward/record.url?scp=85056760776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056760776&partnerID=8YFLogxK
U2 - 10.1016/j.mcna.2018.08.006
DO - 10.1016/j.mcna.2018.08.006
M3 - Review article
C2 - 30466670
AN - SCOPUS:85056760776
VL - 103
SP - 137
EP - 152
JO - Medical Clinics of North America
JF - Medical Clinics of North America
SN - 0025-7125
IS - 1
ER -